World journal of gastroenterology · 2014
Benign giant-cell tumor of the common bile duct: a case report.
Клинический случайСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Dan-Dan, Zheng Ya-Min, Teng Liang-Hong, Sun Yan-Ni, Gao Wei, Wang Lei-Ming, Wang Yue-Hua, Li Fei, Lu De-Hong
Аннотация
Primary giant-cell tumors rarely arise in the common bile duct. We herein report a case of primary giant-cell tumor of the common bile duct. The patient was an 81-year-old male who was diagnosed with a well-defined 1.2-cm mass projecting into the lumen of the middle common bile duct. Excision of the gallbladder and extrahepatic bile duct and a Roux-en-Y cholangiojejunostomy were performed. Histologically, the tumor had no association with carcinomas of epithelial origin and was similar to giant-cell tumors of the bone. The tumor consisted of a mixture of mononuclear and multinucleated osteoclast-like giant cells. The mononuclear cells showed no atypical features, and their nuclei were similar to those of the multinucleated giant cells. CD68 was expressed on the mononuclear and multinucleated osteoclast-like giant cells, whereas CD163 immunoreactivity was restricted to the mononuclear cells. Six months after the operation, the patient was still alive and had no recurrence. The interest of this case lies in the rarity of this entity, the difficulty of preoperative diagnosis, and this tumor's possible confusion with other malignant tumors.
Предметные рубрики MeSH
Aged, 80 and overAnastomosis, Roux-en-YAntigens, CDAntigens, Differentiation, MyelomonocyticBiomarkers, TumorBiopsyCholangiopancreatography, Magnetic ResonanceCholecystectomyCommon Bile Duct NeoplasmsGiant Cell TumorsHumansImmunohistochemistryJejunostomyMaleReceptors, Cell SurfaceTomography, X-Ray ComputedTreatment OutcomeTumor BurdenCD163 AntigenCD68 Molecule